levocarnitine and its Impurities
It is a drug used to treat lack of carnitine(an amino acid derivative used to metabolise lipids in mammals). Levocarnitine is a prescription nutritional supplement given to patients who do not have enough carnitine in their body. Reference standards of Levocarnitine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
 
	
			                                   
																				Levocarnitine Related Compound A (2-propen-1-aminium, 3-carboxy-N,N,N-trimethyl-, chloride) (1359925)
Levocarnitine Related Compound A (2-propen-1-aminium, 3-carboxy-N,N,N-trimethyl-, chloride) (1359925)
- Catalogue No.:PA USP1359925 
- CAS : - 6538-82-5
- Molecular Formula : NA 
- Molecular Weight : NA 
 
	
			                                   
																				1-Propanaminium, 3-chloro-2-hydroxy-N,N,N-trimethyl-, chloride, (2S)-, compd. with (1R)-[1,1′-binaphthalene]-2,2′-diol
1-Propanaminium, 3-chloro-2-hydroxy-N,N,N-trimethyl-, chloride, (2S)-, compd. with (1R)-[1,1′-binaphthalene]-2,2′-diol
- Catalogue No.:PA 12 0301006 
- CAS : - 765950-50-3
- Molecular Formula : C26H29Cl2NO3 
- Molecular Weight : 474.42 

 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
 
 
 
